Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopaminergic Modulation of Prefrontal Functions in Schizophrenic Patients: Adjuvant Therapy With Pergolide

NCT01066403 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01066403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopaminergic Modulation of Prefrontal Functions in Schizophrenic Patients: Adjuvant Therapy With Pergolide
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2003
Completion date
March 31, 2008
Enrollment
28 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia